Evidence map›Paper›PMID 42795628›Full record

ReviewMicroorganisms2026

Lassa Virus-A Persistent and Evolving Threat.

Meng Hu, Emily Mantlo, Cheng Huang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Meng HuDepartment of Pathology and Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77550, USA.
Emily MantloDepartment of Microbiology and Immunology, Global Health Institute, Upstate Medical University, Syracuse, NY 13210, USA.
Cheng HuangDepartment of Pathology and Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77550, USA.ORCID 0000-0001-5402-353X

Funding

New role of NP Exoribonuclease in Lassa virus infectionR01AI187204 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Cheng Huang · 2025 to 2026
$1.1M
Novel Function(s) of Arenavirus NP ExoribonucleaseR21AI166985 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI HUANG, CHENG · 2022 to 2023
$440k
National Institute of Allergy and Infectious Diseases 5R01AI187204National Institute of Allergy and Infectious Diseases 5R21AI166985NIAID NIH HHS R01 AI187204NIAID NIH HHS R21 AI166985
6 · The paper itself

Abstract

Lassa virus (LASV), the most important human pathogen within the

Indexed as

geographic distributioninfectionLassa feverLASVmedical countermeasurespathogenesispathogenicitytransmission

Identifiers

PMID42795628
PMCPMC13609318

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.